These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30793751)

  • 1. Together towards a common goal: REVIVE, a community of antimicrobial researchers brought together by the Global Antibiotic Research & Development Partnership (GARDP).
    Pentz-Murr A; Piddock LJV
    J Antimicrob Chemother; 2019 Jul; 74(7):1769-1770. PubMed ID: 30793751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Global Antibiotic Research and Development Partnership (GARDP): a not-for-profit antibiotic development organisation.
    Piddock LJ;
    Lancet Infect Dis; 2018 Dec; 18(12):1304-1305. PubMed ID: 30420229
    [No Abstract]   [Full Text] [Related]  

  • 3. (Inter)nationalising the antibiotic research and development pipeline.
    Singer AC; Kirchhelle C; Roberts AP
    Lancet Infect Dis; 2020 Feb; 20(2):e54-e62. PubMed ID: 31753765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic development - economic, regulatory and societal challenges.
    Årdal C; Balasegaram M; Laxminarayan R; McAdams D; Outterson K; Rex JH; Sumpradit N
    Nat Rev Microbiol; 2020 May; 18(5):267-274. PubMed ID: 31745330
    [No Abstract]   [Full Text] [Related]  

  • 5. Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board.
    Spellberg B; Nielsen TB; Gilbert DN; Shorr AF; Brass EP
    Ann Intern Med; 2019 Oct; 171(8):580-582. PubMed ID: 31590184
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic Pipeline Coordinators.
    Baraldi E; Lindahl O; Savic M; Findlay D; Årdal C
    J Law Med Ethics; 2018 Jun; 46(1_suppl):25-31. PubMed ID: 30146958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development.
    Balasegaram M; Piddock LJV
    ACS Infect Dis; 2020 Jun; 6(6):1295-1298. PubMed ID: 32406675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partnerships for better neglected disease drug discovery and development: how have we fared?
    Sunyoto T
    Expert Opin Drug Discov; 2020 May; 15(5):531-537. PubMed ID: 32129688
    [No Abstract]   [Full Text] [Related]  

  • 9. Bridging the gap: engaging researchers and advocates to build support for TB vaccine research and development.
    Kennell M; Woolley J
    Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S30-2. PubMed ID: 22441157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Call for the creation of an international panel on antimicrobial resistance.
    Vet Rec; 2014 May; 174(22):541. PubMed ID: 24920704
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic research and development: business as usual?
    Harbarth S; Theuretzbacher U; Hackett J;
    J Antimicrob Chemother; 2015; 70(6):1604-7. PubMed ID: 25673635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
    Kostyanev T; Bonten MJ; O'Brien S; Steel H; Ross S; François B; Tacconelli E; Winterhalter M; Stavenger RA; Karlén A; Harbarth S; Hackett J; Jafri HS; Vuong C; MacGowan A; Witschi A; Angyalosi G; Elborn JS; deWinter R; Goossens H
    J Antimicrob Chemother; 2016 Feb; 71(2):290-5. PubMed ID: 26568581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priority pathogens and the antibiotic pipeline: an update.
    Beyer P; Paulin S
    Bull World Health Organ; 2020 Mar; 98(3):151. PubMed ID: 32132745
    [No Abstract]   [Full Text] [Related]  

  • 14. Policy: An intergovernmental panel on antimicrobial resistance.
    Woolhouse M; Farrar J
    Nature; 2014 May; 509(7502):555-7. PubMed ID: 24877180
    [No Abstract]   [Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are the economic barriers of antibiotic R&D and how can we overcome them?
    Renwick M; Mossialos E
    Expert Opin Drug Discov; 2018 Oct; 13(10):889-892. PubMed ID: 30175625
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges and Opportunities with Antibiotic Discovery and Exploratory Research.
    Piddock LJV; Malpani R; Hennessy A
    ACS Infect Dis; 2024 Jul; ():. PubMed ID: 39037946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roadmap for antibiotic discovery.
    Shore CK; Coukell A
    Nat Microbiol; 2016 May; 1(6):16083. PubMed ID: 27572847
    [No Abstract]   [Full Text] [Related]  

  • 19. [Public health international research: research scientist-field worker partnership, interdisciplinarity and social role].
    Alla F; Kivits J
    Sante Publique; 2015; 27(3):303-4. PubMed ID: 26414130
    [No Abstract]   [Full Text] [Related]  

  • 20. [International Partnership for Therapeutic Drug Development of NTDs by DNDi].
    Yamada H; Hirabayashi F; Brünger C
    Yakugaku Zasshi; 2016; 136(2):213-22. PubMed ID: 26831796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.